Literature DB >> 19888587

Association between adiponectin, resistin, insulin resistance, and colorectal tumors.

Guzin Gonullu1, Hakki Kahraman, Abdulkerim Bedir, Ahmet Bektas, Idris Yücel.   

Abstract

PURPOSE: In this study, we have examined the correlation between colorectal cancer (CRC) and serum adiponectin and resistin levels, body mass index and insulin resistance.
METHODS: The relation between serum adiponectin and resistin levels, obesity and insulin resistance in 36 CRC patients and 37 controls was examined.
RESULTS: Insulin and homeostasis model assessment insulin resistance index (HOMA-IR) levels were higher, and adiponectin levels were significantly decreased in patients versus controls, whereas, resistin levels were significantly increased. A negative correlation between adiponectin, HOMA-IR, and insulin and a positive correlation between HOMA-IR, insulin, and stage were detected. There was no correlation between the stage and resistin. Adiponectin level negatively correlated with the stage. Adiponectin and resistin could play a role in colon cancer carcinogenesis, and adiponectin could be responsible for poor prognosis in colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888587     DOI: 10.1007/s00384-009-0828-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  48 in total

1.  Serum adiponectin is not associated with risk of colorectal cancer.

Authors:  Annekatrin Lukanova; Stefan Söderberg; Rudolf Kaaks; Egil Jellum; Pär Stattin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-02       Impact factor: 4.254

2.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

3.  Prostate cancer and adiponectin.

Authors:  Serdar Goktas; Mahmut Ilker Yilmaz; Kayser Caglar; Alper Sonmez; Selim Kilic; Selahattin Bedir
Journal:  Urology       Date:  2005-06       Impact factor: 2.649

4.  Plasma adiponectin levels in overweight and obese Asians.

Authors:  Wei-Shiung Yang; Wei-Jei Lee; Tohru Funahashi; Sachiyo Tanaka; Yuji Matsuzawa; Chia-Ling Chao; Chi-Ling Chen; Tong-Yuan Tai; Lee-Ming Chuang
Journal:  Obes Res       Date:  2002-11

5.  Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions.

Authors:  Daiji Kawanami; Koji Maemura; Norihiko Takeda; Tomohiro Harada; Takefumi Nojiri; Yasushi Imai; Ichiro Manabe; Kazunori Utsunomiya; Ryozo Nagai
Journal:  Biochem Biophys Res Commun       Date:  2004-02-06       Impact factor: 3.575

6.  Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity.

Authors:  Bulent O Yildiz; Marc A Suchard; Ma-Li Wong; Samuel M McCann; Julio Licinio
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

7.  Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients.

Authors:  Anna Kumor; Piotr Daniel; Mirosława Pietruczuk; Ewa Małecka-Panas
Journal:  Int J Colorectal Dis       Date:  2008-11-01       Impact factor: 2.571

8.  Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia.

Authors:  Elife Erarslan; Cansel Turkay; Aslý Koktener; Cemile Koca; Burak Uz; Nuket Bavbek
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

9.  Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

Authors:  Ebba Bråkenhielm; Niina Veitonmäki; Renhai Cao; Shinji Kihara; Yuji Matsuzawa; Boris Zhivotovsky; Tohru Funahashi; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

10.  Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns.

Authors:  Alina Gavrila; C-K Peng; Jean L Chan; Joseph E Mietus; Ary L Goldberger; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

View more
  39 in total

1.  Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk.

Authors:  Mathilde Touvier; Léopold Fezeu; Namanjeet Ahluwalia; Chantal Julia; Nathalie Charnaux; Angela Sutton; Caroline Méjean; Paule Latino-Martel; Serge Hercberg; Pilar Galan; Sébastien Czernichow
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

2.  Insulin resistance, central obesity, and risk of colorectal adenomas.

Authors:  Ana Patricia Ortiz; Cheryl L Thompson; Amitabh Chak; Nathan A Berger; Li Li
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

3.  Comparison of adiponectin concentration between pancreatic cancer and colorectal cancer.

Authors:  Jean Marc Phelip; Serban Bageacu; Mathieu Baconnier; Gabriele Barabino; Emilie Del Tedesco; Pierre Yves Benhamou; Xavier Roblin
Journal:  J Gastrointest Oncol       Date:  2011-12

Review 4.  Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis.

Authors:  Shahab Uddin; Azhar R Hussain; Omar S Khan; Khawla S Al-Kuraya
Journal:  Tumour Biol       Date:  2013-09-07

5.  Associations between polymorphisms in the SYK promoter and susceptibility to sporadic colorectal cancer in a Southern Han Chinese population - a short report.

Authors:  Hui Peng; Jun Huang; Ying Hu; Yisheng Wei; Huanliang Liu; Meijin Huang; Lei Wang; Jianping Wang
Journal:  Cell Oncol (Dordr)       Date:  2015-04-29       Impact factor: 6.730

6.  Genetic analysis of ADIPOQ variants and gastric cancer risk: a hospital-based case-control study in China.

Authors:  Lei Ye; Zuo-Yang Zhang; Wei-Dong Du; Marion E Schneider; Yue Qiu; Yuan Zhou; Fu-Sheng Zhou; Xian-Bo Zuo; Gang Chen; Xue-Ling Ma; Hong-Zhen Xia; Song Xu; Ji-Feng Wu; Hong-Yuan Xu; Xue-Jun Zhang
Journal:  Med Oncol       Date:  2013-07-25       Impact factor: 3.064

Review 7.  The role of adiponectin in cancer: a review of current evidence.

Authors:  Maria Dalamaga; Kalliope N Diakopoulos; Christos S Mantzoros
Journal:  Endocr Rev       Date:  2012-04-30       Impact factor: 19.871

8.  Association of leptin, visfatin, apelin, resistin and adiponectin with clear cell renal cell carcinoma.

Authors:  Hai-Ping Zhang; Jian Zou; Zhuo-Qun Xu; Jun Ruan; Shu-Dong Yang; Ying Yin; Hui-Jun Mu
Journal:  Oncol Lett       Date:  2016-11-22       Impact factor: 2.967

Review 9.  Adiponectin and colorectal cancer.

Authors:  Kensuke Otani; Soichiro Ishihara; Hironori Yamaguchi; Koji Murono; Koji Yasuda; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Keisuke Hata; Kazushige Kawai; Hiroaki Nozawa; Toshiaki Watanabe
Journal:  Surg Today       Date:  2016-04-09       Impact factor: 2.549

Review 10.  Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis.

Authors:  Rakhi Kumari Joshi; Woo Jin Kim; Sang-Ah Lee
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.